5.96
price down icon3.09%   -0.19
after-market Handel nachbörslich: 5.96
loading

Verrica Pharmaceuticals Inc Aktie (VRCA) Neueste Nachrichten

pulisher
06:24 AM

Sentiment analysis tools applied to Verrica Pharmaceuticals Inc.Wall Street Watch & Long-Term Investment Growth Plans - Newser

06:24 AM
pulisher
04:33 AM

Real time social sentiment graph for Verrica Pharmaceuticals Inc.2025 EndofYear Setup & Intraday High Probability Alerts - Newser

04:33 AM
pulisher
03:05 AM

Sector ETF Data Correlates with Strength in Verrica Pharmaceuticals Inc.Trade Analysis Report & Growth Oriented Trading Recommendations - sundaytimes.kr

03:05 AM
pulisher
Aug 14, 2025

What makes Verrica Pharmaceuticals Inc. stock price move sharply2025 Earnings Surprises & Stock Portfolio Risk Control - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Market reaction to Verrica Pharmaceuticals Inc.’s recent newsOptions Play & Weekly Breakout Watchlists - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Historical volatility pattern of Verrica Pharmaceuticals Inc. visualized2025 Major Catalysts & Long Hold Capital Preservation Plans - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Can Verrica Pharmaceuticals Inc. recover in the next quarterEarnings Growth Summary & Stock Portfolio Risk Control - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals shares rise 2.28% after-hours following Q2 2025 earnings call. - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals stock price target raised to $20 by TD Cowen - Investing.com Canada

Aug 13, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals Reaches Nasdaq Compliance, Q2 Revenue at $12.7M - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 13, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates - MSN

Aug 13, 2025
pulisher
Aug 13, 2025

Why Verrica Pharmaceuticals Inc. stock attracts strong analyst attentionJobs Report & High Win Rate Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlig - GuruFocus

Aug 13, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals Sees Revenue Surge in Q2 2025 - TipRanks

Aug 13, 2025
pulisher
Aug 13, 2025

Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewswire

Aug 13, 2025
pulisher
Aug 12, 2025

Verrica Posts Profit in Fiscal Q2 - The Motley Fool

Aug 12, 2025
pulisher
Aug 12, 2025

Verrica Posts Profit in Fiscal Q2 - Nasdaq

Aug 12, 2025
pulisher
Aug 12, 2025

Verrica Pharmaceuticals' Q2 2025: Unpacking Contradictions in Sales Strategies, Seasonality, and Patient Access - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Verrica Pharmaceuticals (VRCA) Q2 2025 Earnings and Strategic Pipeline Catalysts: A Case for Re-Rating and Investor Re-Entry - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Earnings call transcript: Verrica Pharmaceuticals Q2 2025 beats EPS forecast By Investing.com - Investing.com Nigeria

Aug 12, 2025
pulisher
Aug 12, 2025

VERRICA PHARMACEUTICAL Earnings Results: $VRCA Reports Quarterly Earnings - Quiver Quantitative

Aug 12, 2025
pulisher
Aug 12, 2025

Verrica Pharmaceuticals earnings beat by $0.11, revenue topped estimates - Investing.com Canada

Aug 12, 2025
pulisher
Aug 11, 2025

Verrica Pharmaceuticals Inc. stock trend outlook and recovery pathFree Short Term Trading Opportunity Watch - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Verrica Pharmaceuticals Inc (VRCA) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Aug 11, 2025
pulisher
Aug 09, 2025

Verrica VRCA 2025Q2 Earnings Preview Upside Potential on Strategic Expansion Plans - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Verrica Pharmaceuticals to Report Q2 Results on August 12 - MSN

Aug 09, 2025
pulisher
Aug 08, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives $80.00 Average PT from Analysts - Defense World

Aug 08, 2025
pulisher
Aug 08, 2025

Is Verrica Pharmaceuticals Inc. showing signs of accumulationEarnings Impact and Stock Reaction Analysis - Newser

Aug 08, 2025
pulisher
Aug 07, 2025

Verrica Pharmaceuticals to Report Second Quarter 2025 Financial - GuruFocus

Aug 07, 2025
pulisher
Aug 06, 2025

Verrica Pharmaceuticals to Report Q2 2025 Financial Results and Provide Corporate Update on Aug 12, 2025. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Verrica Pharmaceuticals to host Q2 earnings call on August 12, 2025. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Verrica Pharmaceuticals: A Strategic Leap from Niche to Diversified Biotech Leader - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Verrica Pharmaceuticals to report second quarter 2025 financial results and provide a corporate update on August 12, 2025 - MarketScreener

Aug 06, 2025
pulisher
Aug 06, 2025

Verrica Pharmaceuticals (VRCA): A Turning Point in 2025 Q2 Earnings and Strategic Momentum - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Verrica Pharmaceuticals to Report Second Quarter 2025 - GlobeNewswire

Aug 06, 2025
pulisher
Aug 06, 2025

Verrica Pharmaceuticals Sets Q2 Earnings Date: Key Updates Expected on Dermatology Pipeline - Stock Titan

Aug 06, 2025
pulisher
Aug 05, 2025

Common Warts Clinical Trials, Companies, Therapeutic - openPR.com

Aug 05, 2025
pulisher
Aug 05, 2025

Common Warts Clinical Trials, Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, Pipeline Analysis | Verrica Pharmaceuticals, X4 Pharmaceuticals, Phio Pharmaceuticals, Kino Ph - Barchart.com

Aug 05, 2025
pulisher
Aug 04, 2025

Verrica Pharmaceuticals Inc. Consolidation Zone May Signal AccumulationTrade Setups With Clear Risk Limits Highlighted - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Published on: 2025-08-04 09:22:19 - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

What drives Verrica Pharmaceuticals Inc. stock priceAchieve rapid capital gains with smart investing - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Verrica Pharmaceuticals Inc. stockAchieve consistent profits with disciplined trading - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Verrica Pharmaceuticals Inc. stock compared to the marketUnmatched profit potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Verrica Pharmaceuticals Inc. stockMaximize gains with proven stock analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Verrica Pharmaceuticals Inc. stock in 2025Unlock market-leading stock analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Verrica Pharmaceuticals Inc. stock attracting strong analyst attentionOutstanding capital appreciation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Verrica Pharmaceuticals Inc. stockOutperformance with explosive growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What are the technical indicators suggesting about Verrica Pharmaceuticals Inc.Free Investment Community - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How does Verrica Pharmaceuticals Inc. compare to its industry peersCapitalize on fast-moving trading opportunities - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

How many analysts rate Verrica Pharmaceuticals Inc. as a “Buy”Beginner Investor Insights That Work - jammulinksnews.com

Aug 01, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):